Shree Ganesh Biotech (India) L

BSE: 539470 29 Jul 2025

Healthcare

₹ 0.83

Shree Ganesh Biotech (India) Limited specializes in Biotechnology within the Healthcare sector.

Shree Ganesh Biotech (India) L

BSE: 539470 29 Jul 2025

Healthcare

₹ 0.83

Shree Ganesh Biotech (India) Limited specializes in Biotechnology within the Healthcare sector.

Book Value

1.59

Dividend Yield

0.0%

Debt to Equity

0.0

Stock P/E

67.0

Market Cap

31.5 Cr

Shree Ganesh Biotech (India) L - Share Price & Details

Market Cap

₹31.5

High /Low

1.29 / 0.79

Stock P/E

67.0

Book Value

₹1.59

Dividend Yield

0.0

ROCE

0.62

ROE

₹0.44

Face Value

1.0

PEG Ratio

-1.29

EVEBITDA

₹67.0

Debt

0.00

CMP / FCF

9.01

Debt to equity

₹0.0

NP Ann

0.28

High price all time

24.7

Piotroski score

₹4.0

Graham Number

0.65

No. Eq. Shares

39.9

Net CF

₹-0.41

Net profit

0.47

Price to book value

0.5

Interest Coverage

₹NA

Low price all time

0.7

Industry PE

58.3

Reserves

₹23.4

Free Cash Flow

₹-10.2

Price Chart

Volume Chart

Peer Comparison

Stock	Total Income	Net Profit	Net Sales	EPS	Market Cap (in Cr)	P/E
FABINO ENTERPRISES LIMITED	NA	NA	NA	NA	5.46	91.0
Triochem Products Ltd.,	3.25	-4.52	NA	-18.44	0
Shree Ganesh Biotech (India) L	34.71	-9.46	30.06	-0.02	31.5	67.0
KK Shah Hospitals Limited	NA	NA	NA	NA	30.3
SHREE PACETRONIX LTD.	43.06	4.66	42.80	1.29	28.3	37.7

Peer Comparison Chart

About Shree Ganesh Biotech (India) L

Shree Ganesh Biotech (India) Limited, with Security Code 539470, is a leading player in the Biotechnology industry, categorized under the Healthcare sector, offering Equity instruments.

Latest News

Shree Ganesh Biotech India reports standalone net loss of Rs 0.95 crore in the March 2025 quarter

(23 May 2025)

Sales decline 20.37% to Rs 3.01 crore. Net loss of Shree Ganesh Biotech India reported to Rs 0.95 crore in the quarter ended March 2025 as against net...

ShreeGanesh Bio Standalone March 2025 Net Sales at Rs 3.01 crore, down 20.55% Y-o-Y

(23 May 2025)

Net Sales at Rs 3.01 crore in March 2025 down 20.55% from Rs. 3.78 crore in March 2024. Story continues below Advertisement.

Indo Amines consolidated net profit rises 29.93% in the March 2025 quarter

(23 May 2025)

Net profit of Indo Amines rose 29.93% to Rs 11.85 crore in the quarter ended March 2025 as against Rs 9.12 crore during the previous quarter ended March 2024.

McNally Bharat Engineering Company reports consolidated net loss of Rs 998.97 crore in the March 2025 quarter

(23 May 2025)

Sales decline 24.71% to Rs 30.38 crore.

Earnings Today: ITC, Sun Pharma, Grasim, Honasa Consumer Among 150+ Firms Set To Declare Q4 Results

(22 May 2025)

Over 150 companies are lined up to announce their Q4 results today, making it one of the busiest days in the earnings season.

Q4 results today: ITC, Sun Pharma, GMR Airports on May 22; see full list

(22 May 2025)

Q4 FY25 company results today: Emcure Pharmaceuticals, Honasa Consumers, and Reliance Home Finance will be among 164 companies to post...

Quarterly Table

Standalone

Metrics	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025
Sales	12.1	8.0	8.3	4.1	4.1	3.8	3.6	2.0	14.4	3.0
Expenses	11.8	8.5	8.1	4.0	4.0	4.3	3.7	2.0	13.9	4.4
Operating Profit	0.3	-0.5	0.2	0.1	0.1	-0.5	-0.1	0.0	0.5	-1.4
OPM %	2.22%	-6.09%	1.82%	1.82%	2.11%	-13.53%	-3.68%	1.01%	3.25%	-46.34%
Other Income	0.0	0.6	0.0	0.0	0.0	1.1	0.4	0.3	0.3	0.5
Interest	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Depreciation	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Profit before tax	0.3	0.1	0.2	0.1	0.1	0.5	0.2	0.3	0.8	-0.9
Tax %	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%
Net Profit	0.3	0.1	0.1	0.1	0.1	0.5	0.2	0.3	0.8	-0.9
EPS in Rs	0.01					0.01	0.01	0.01	0.02	0

Shareholding Distribution

Shareholding Pattern

Compounded Data

Consolidated

Standalone

Compounded Sales Growth
10 Years:	30%
5 Years:	56%
3 Years:	-32%
TTM:	13%

Compounded Profit Growth
10 Years:	-2%
5 Years:	3%
3 Years:	-52%
TTM:	-55%

Stock Price CAGR
10 Years:	0%
5 Years:	-32%
3 Years:	-32%
1 Year:	-23%

Compounded Sales Growth
10 Years:	0%
5 Years:	0%
3 Years:	0%
TTM:	0%

Compounded Profit Growth
10 Years:	0%
5 Years:	0%
3 Years:	0%
TTM:	0%

Stock Price CAGR
10 Years:	0%
5 Years:	0%
3 Years:	0%
1 Year:	0%

All Deals

Date	Stock	Party	Deal	Acq. Mode	Trans.	Quan.	Price	Value

Shree Ganesh Biotech (India) L

Shree Ganesh Biotech (India) L

Shree Ganesh Biotech (India) L - Share Price & Details

Price Chart

Volume Chart

Peer Comparison

Peer Comparison Chart

About Shree Ganesh Biotech (India) L

Latest News

Shree Ganesh Biotech India reports standalone net loss of Rs 0.95 crore in the March 2025 quarter

ShreeGanesh Bio Standalone March 2025 Net Sales at Rs 3.01 crore, down 20.55% Y-o-Y

Indo Amines consolidated net profit rises 29.93% in the March 2025 quarter

McNally Bharat Engineering Company reports consolidated net loss of Rs 998.97 crore in the March 2025 quarter

Earnings Today: ITC, Sun Pharma, Grasim, Honasa Consumer Among 150+ Firms Set To Declare Q4 Results

Q4 results today: ITC, Sun Pharma, GMR Airports on May 22; see full list

Q4 Results Today: ITC, Grasim Industries, Sun Pharma, Container Corp Among 160+ Firms To Declare Earnings

Shree Ganesh Biotech Reports Strong Sales Growth Amid Profitability Challenges in May 2025

Q4 results: इस हफ्ते ITC, Bharat Electronics समेत कई दिग्गज कंपनियों के आएंगे नतीजे, चेक करें पूरी लिस्ट

Q4 results: ITC, Sun Pharma, GMR Airports, Honasa, and others to declare earnings today; check list

Q4 Results 2025: Over 700 Companies To Declare Earnings This Week, Full List Here

Q4 results: Bharat Electronics, DLF, IRB Infra, Jupiter Wagons, Indigo, IndusInd Bank, EIH Hotels, Power Grid among 700 companies to announce results this week

Stock market today: NIFTY50 crosses 25,000 for first time in seven months, here's why

ITC Hotels Q4 Results: Shares down 0.5% ahead of earnings; key things you need to know

Shree Ganesh Biotech Faces Significant Financial Challenges Amidst Market Volatility

Shree Ganesh Biotech Faces Severe Financial Challenges Amidst Ongoing Stock Decline

Shree Ganesh Biotech Faces Market Challenges Amid Weak Financial Fundamentals

Shree Ganesh Biotech Faces Significant Challenges Amidst Ongoing Stock Volatility

ShreeGanesh Bio Standalone December 2024 Net Sales at Rs 14.41 crore, up 249.59% Y-o-Y

Penny stock jumps 15% after reporting 756% YoY increase in net profits

98 पैसे के शेयर को खरीदने की होड़, 15% चढ़ गया भाव, 755% बढ़ा है कंपनी का मुनाफा, आपका है दांव?

Shree Ganesh Biotech India standalone net profit rises 755.56% in the December 2024 quarter

Q3 Results Today: Asian Paints, Tata Power, MobiKwik, Titan, PC Jeweller Among 130 Firms Declaring Earnings

Quick Wrap: Nifty PSE Index records a surge of 2.72%, NIFTY climbs 1.62%

Shree Ganesh Biotech Hits 52-Week Low Amid Broader Agriculture Sector Decline

Shree Ganesh Jewellery House plans debt amid gold import curbs | Company Business News

Hyundai Motor India, P N Gadgil Jewellers Among 500+ Companies To Declare Q2 Results Today

Shree Ganesh Biotech India standalone net profit rises 300.00% in the September 2024 quarter

ShreeGanesh Bio Standalone September 2024 Net Sales at Rs 1.98 crore, down 51.82% Y-o-Y

Shree Ganesh Bio's Q2 FY25 Financial Results Show Mixed Performance

Sajan Pillai to set up US $75 million VC fund for startups | Company Business News

Q2 results today: HUL, Godrej Properties, AU Small Finance, TVS Motor among 73 companies to post earnings on October 23 | Company Business News

HUL, SBI Life, United Spirits, Bajaj Finserv Among 70+ Companies To Declare Q2 Results Today

Bajaj Finserv, Hindustan Unilever, TVS Motor among 73 companies set to post Q2FY25 results today

Bajaj Finserv, HUL & Piditlite, Along With 70 Others, To Declare Their Q2 Earnings

Indices slide for 3rd day, Nifty ends below 24,450; M&M drops 3%

Navin Fluorine International consolidated net profit declines 2.91% in the September 2024 quarter

Top 10 seeds companies in India in 2024

Weaver Services acquires Capital India Home Loans for ₹267 crore | Company Business News

Over 100 stocks hit upper circuits despite market crash; do you own any?

श्री गनेश बयोटेक इन्डीया लिमिटेड शेयर प्राइस

ShreeGanesh Bio Standalone June 2024 Net Sales at Rs 3.56 crore, down 56.92% Y-o-Y

Starlineps Enterprises Ltd leads losers in 'B' group

Q1 Results, Aug. 13: IRCTC, Hero MotoCorp, SJVN, Hindalco To Declare Earnings Today

523 Companies To Post Q1 Results Today: Check Whether Your Stock Is One Of Them

Shree Ganesh Biotech India standalone net profit rises 60.00% in the June 2024 quarter

Shree Ganesh Biotech India Announces Q1 Financial Results, Stock Receives 'Strong Sell' Rating

Odisha govt approves 26 projects worth Rs 5,992.92 crore

Odisha Govt Okays 26 Projects Worth Rs 5,992.92 Cr to Create 19,364 Jobs

Q4 results today: Reliance Infra, Muthoot among 908 firms to post earnings

Shree Ganesh Remedies standalone net profit rises 87.91% in the March 2024 quarter

ShreeGanesh Bio Standalone March 2024 Net Sales at Rs 3.78 crore, down 52.58% Y-o-Y

Q4 Results Today: Reliance Infra, Muthoot Finance, Apollo Hospitals among 908 companies to post earnings on May 30 | Company Business News

Q4 Results Today: Tata Steel, Cummins India, Lemon Tree Hotels Among 560+ Companies To Report Earnings

Q4 Results Today: Tata Steel, Alkem Laboratories, Emami, Heritage Foods among 566 companies to post earnings on May 29 | Company Business News

Shree Ganesh Biotech India Ltd

Shree Ganesh Biotech India's Financial Performance Declines

Q3 Results Today: ZEEL, HAL, GlaxoSmithKline Pharma, Honda India Power and more to post earnings on February 12 | Company Business News

Q3 Results Today: RBL Bank, ICICI Bank, Kotak Bank, IREDA, IDFC First Bank To Report Earnings

Stocks below Re 1 which gave good returns in last one month

Top 10 seeds companies in India

ShreeGanesh Bio Standalone June 2023 Net Sales at Rs 8.25 crore, down 59.76% Y-o-Y

Shree Ganesh Biotech India Ltd Share Price Today, null Share Price NSE, BSE

Shree Ganesh Biotech India Share Price Today - Shree Ganesh Biotech India Stock Price Live NSE/BSE

5 Pharma Stocks Down More Than 70% From Their 52 Week High Levels

3 Stocks To Turn Ex-Bonus Next Week: All You Need To Know

Shree Ganesh Biotech (India) jumps after board OKs 1:1 bonus issue

Schaeffler India, Shree Ganesh Biotech, Bhatia Communications and Retail, and JBM Auto will split their stock in February 2022

Shree Ganesh Biotech India to consider bonus shares issue, stock surges | Stock Market News

Shree Ganesh Biotech बोनस शेयर जारी करने पर करेगी विचार, 5% चढ़ा स्टॉक

Shree Ganesh Biotech India to consider bonus shares issue, stock surges